Kamada (KMDA) Inventory (2012 - 2026)
Kamada's (KMDA) quarterly Inventory came in at $86.9 million in Q2 2026, up 5.84% on a YoY basis from $82.1 million in Q2 2025, and up 1.68% quarter-over-quarter from $85.4 million in Q1 2026.
Analysis
Kamada (KMDA) Inventory (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Inventory for 15 consecutive years, with $86.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Inventory rose 5.84% year-over-year to $86.9 million; the trailing twelve-month figure through Jun 2026 stood at $86.9 million (up 5.84% YoY), and the FY2025 full-year result was $84.9 million, up 7.77% from the prior year.
- Inventory grew to $86.9 million in Q2 2026 per KMDA's latest filing, from $85.4 million in the prior quarter.
- Across five years, Inventory topped out at $88.5 million in Q4 2023 and bottomed at $64.5 million in Q2 2022.
- Historically, Inventory has averaged $78.3 million across 5 years, with a median of $79.3 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Inventory surged 57.36% in 2022, then slipped 10.92% in 2024.
- Over 5 years, Inventory stood at $68.8 million in 2022, then increased by 28.63% to $88.5 million in 2023, then fell by 10.92% to $78.8 million in 2024, then increased by 7.77% to $84.9 million in 2025, then increased by 2.27% to $86.9 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $86.9 million, $85.4 million, and $84.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.39 Bn | 197.40 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 181.14 Bn | 177.96 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.91 Bn | 74.91 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 61.55 Bn | 56.36 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 54.39 Bn | 49.25 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.43 Bn | 31.12 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 31.18 Bn | 29.89 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn | - |
| 10 | Kamada | 472.70 Mn | 402.57 Mn | 22.47 Mn | 86.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.88 Mn |
| Mar 31, 2026 | 85.44 Mn |
| Dec 31, 2025 | 84.94 Mn |
| Sep 30, 2025 | 85.41 Mn |
| Jun 30, 2025 | 82.08 Mn |
| Mar 31, 2025 | 78.36 Mn |
| Dec 31, 2024 | 78.82 Mn |
| Sep 30, 2024 | 71.56 Mn |
| Jun 30, 2024 | 78.71 Mn |
| Mar 31, 2024 | 84.35 Mn |
| Dec 31, 2023 | 88.48 Mn |
| Sep 30, 2023 | 73.80 Mn |
| Jun 30, 2023 | 80.24 Mn |
| Mar 31, 2023 | 79.75 Mn |
| Dec 31, 2022 | 68.79 Mn |
| Sep 30, 2022 | 73.03 Mn |
| Jun 30, 2022 | 64.52 Mn |
| Mar 31, 2022 | 64.76 Mn |
| Dec 31, 2021 | 67.42 Mn |
| Sep 30, 2021 | 48.16 Mn |